(1 - 22 from 25
)
Harvoni induces high response rates in genotype 4, 5 HCV
www.healio.com
Apr 25, · VIENNA — Patients with genotype 4 and 5 hepatitis C virus benefitted from treatment with Harvoni, according to findings presented at the International Liver Congress. Armand Abergel, MD, of ...
Gilead announces results from studies evaluating sofosbuvir-based...
www.pharmabiz.com
Gilead announces results from studies evaluating sofosbuvir-based regimens in chronic hep C patients with genotypes 2-5
Zepatier for 8 weeks safe, effective for HCV genotypes 1b, 4
www.healio.com
Apr 20, · The first study, presented by Armand Abergel, MD, PhD, from Chu Estaing in France, showed a sustained virologic response rate of 98% among treatment-naive patients with HCV genotype 1b and minimal...
Harvoni induces high response rates in genotype 4, 5 HCVwww.healio.com › hepatitis-c › news › print › hcv-next
www.healio.com
Armand Abergel, MD, of Médecine digestive, Chu Estaing at Université d' Auvergne, Clermont Ferrand in France, and colleagues treated more than 80 patients ...
sorted by relevance / date